Ratings
0
Nobody has rated this yet. Be the first!
Works
7
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance
Estrogen-receptor biology: continuing progress and therapeutic implications
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
